Clinical Trial Update: Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Dose Regimens of BIA 5-453 [Phase 1]

View source ↗

Summary

This Phase 1 trial reports tolerability, pharmacokinetics and pharmacodynamics of multiple rising dose regimens of BIA 5-453 in hypertension; the study has comp…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• BIA 5-453

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Hypertension | Phase 1 | Status: COMPLETED